Cerebral AI Market Strategy Report - Online Therapy

Answer Capsule

Cerebral appears in 11.6% of AI observations across the online therapy category but earns a valid recommendation in only 4.0% of cases, revealing a significant gap between visibility and recommendation power. The platform shows its strongest presence in the evaluation-stage comparison cluster but is consistently displaced by Talkspace and BetterHelp across all buyer stages. Cerebral's clearest weakness is its inability to convert mention presence into shortlist positions, with an average recommended rank of 3.7 and a top-three rate of just 1.6%. The clearest opportunity lies in strengthening the public evidence layer to improve recommendation eligibility, particularly in the pricing and cost cluster where buyer intent is highest.

Who This Report Is For

This report is for marketing, growth, and strategy leaders at Cerebral who need to understand how AI systems are positioning the brand in buyer shortlists and where the gaps exist relative to competitors.

Report Card

• Report type: AI Company Market Strategy Report
• Target company: Cerebral
• Category / market studied: Online Therapy
• Reporting month: June 2026
• AI platforms tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity
• Public high-intent clusters: 3 (Best Online Therapy Platforms, Online Therapy Platform Comparisons, Online Therapy Pricing and Cost)
• AI observations analyzed: 1,252
• Competitors tracked: BetterHelp, Talkspace, Grow Therapy, Brightside Health, Online-Therapy.com, 7 Cups, Amwell, Cerebral, Regain, Calmerry

Executive Summary

The LLM Authority Index benchmark for June 2026 shows Cerebral with a raw mention presence rate of 11.6% across 1,252 observations, placing it in the middle tier of the 10-company online therapy universe. The critical metric, however, is valid recommendation coverage, which stands at just 4.0%. This means Cerebral is referenced in AI responses but is rarely selected for buyer shortlists.

Cerebral's overall net sentiment score of 0.41 is neutral to moderately positive, with 59 positive mentions, 86 neutral mentions, and zero negative mentions. The absence of negative framing is a genuine asset, but neutral mentions dominate at 59.3% of all appearances. AI systems are referencing Cerebral factually without endorsing it as a recommended choice.

The strongest cluster for Cerebral is the evaluation-stage comparison cluster (C02), where the platform achieves a 3.8% valid recommendation coverage and a 2.3% top-three rate. The weakest cluster is the decision-stage pricing cluster (C03), where recommendation coverage is 6.1% but the average recommended rank falls to 4.45, placing Cerebral near the bottom of AI-generated shortlists at the moment buyer intent is highest.

Cerebral's modeled monthly AI authority value is $84,547, representing just 0.4% of the total category opportunity of $21.9 million. That figure is less than 4% of Talkspace's $2.32 million and less than 5% of BetterHelp's $2.09 million. The platform is also being out-recommended by Grow Therapy ($498,635), Brightside Health ($356,867), and Online-Therapy.com ($134,437), all of which have built stronger public evidence layers that AI systems favor for shortlist inclusion.

What Cerebral Is Winning

Cerebral carries zero negative mentions across all 1,252 observations. No AI platform returned cautionary or negative framing of the brand, which is a clean public sentiment profile and a real foundation for building recommendation eligibility.

Cerebral's strongest platform-level performance is on Copilot, where it achieves a 13.9% valid recommendation coverage and a 6.3% top-three rate. Both figures are significantly higher than its performance on other platforms, suggesting Copilot's source layer is more favorable to Cerebral's current public evidence footprint.

On Perplexity, Cerebral achieves a perfect 1.0 net sentiment score, with 4 positive mentions and zero neutral or negative appearances. The sample is small, but when Cerebral is discussed on Perplexity, the framing is uniformly positive.

In the evaluation-stage comparison cluster (C02), Cerebral's 3.8% valid recommendation coverage is its strongest cluster performance, and its 2.3% top-three rate is the highest across all three clusters. Comparison conversations represent the clearest current window of shortlist eligibility for the brand.

Where Cerebral Has the Clearest AI Visibility Gaps

The most significant gap is the conversion of mention presence into recommendation credit. Cerebral appears in 11.6% of all observations but earns a valid recommendation in only 4.0% of cases. That 7.6 percentage point gap means AI systems are aware of Cerebral but are not selecting it for buyer shortlists. For context, Talkspace converts a 70.5% presence rate into 33.3% recommendation coverage, and BetterHelp converts 59.5% into 22.8%. Cerebral's conversion rate is among the lowest in the category.

On Gemini, Cerebral has zero valid recommendations despite appearing in 2.6% of observations. All 6 Gemini mentions are classified as neutral, meaning the platform is referenced but never recommended. This is a complete recommendation gap on a major AI platform.

Cerebral's average recommended rank of 3.7 places it at the bottom of most AI-generated shortlists. When Cerebral is recommended, it typically appears in the fourth position or lower. The 1.6% top-three rate means Cerebral earns a top-three shortlist position in fewer than 2 out of every 100 observations across the full dataset.

In the decision-stage pricing cluster (C03), Cerebral's average recommended rank falls to 4.45, the worst performance across all three clusters. This is the highest-intent buyer stage, and Cerebral is being placed near the bottom of shortlists precisely when buyers are ready to choose.

Cerebral is being out-recommended by Grow Therapy by a factor of nearly 6x in modeled monthly AI authority value ($498,635 vs. $84,547). Brightside Health, with a mention presence rate of 22.8%, earns 4.2x more recommendation value than Cerebral. These competitors have built public evidence layers that AI systems trust for shortlist inclusion, and the gap is visible across clusters and platforms.

Biggest Opportunity

Cerebral's biggest opportunity is to close the gap between mention presence and recommendation coverage by strengthening the public evidence layer that AI systems use to build shortlists. The platform has clean sentiment and moderate visibility but lacks the authoritative source signals that drive recommendation eligibility. The pricing and cost cluster (C03) represents the highest commercial value per observation, and Cerebral's 6.1% recommendation coverage against a 15.0% mention presence rate in that cluster points to a direct path for improvement. Building clinical references, verified review content, comparison articles, and authoritative citations that frame Cerebral as a top choice rather than an available option would improve recommendation rates across all buyer stages, with the pricing cluster offering the clearest near-term leverage.

Prompt Evidence

Copilot / Online Therapy Platform Comparisons Prompt: "Compare online therapy platforms for anxiety treatment" Result: Cerebral was mentioned in the response but was not placed in the top three shortlist positions.

ChatGPT / Best Online Therapy Platforms Prompt: "What are the best online therapy platforms?" Result: Cerebral appeared as a listed option but did not rank in the top three recommendations.

Google AI Mode / Online Therapy Pricing and Cost Prompt: "How much does online therapy cost per month?" Result: Cerebral was referenced in a pricing comparison but placed near the bottom of the shortlist with an average rank of 6.8.

Perplexity / Best Online Therapy Platforms Prompt: "Recommend online therapy platforms with good reviews" Result: Cerebral received a positive mention with a rank-one position, though the sample was limited to 4 observations.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map Cerebral's full prompt-level response patterns across all six AI platforms to identify exactly which prompts produce mentions versus recommendations and which sources are driving each outcome.

Phase 2: Recommendation Readiness Plan Identify the specific source gaps that prevent Cerebral from converting mention presence into recommendation credit, focusing on the comparison and pricing clusters where buyer intent is highest.

Phase 3: Owned Answer Layer Buildout Develop structured content that positions Cerebral as a top recommendation for specific therapy needs, insurance acceptance, and pricing transparency, optimized for AI retrievability.

Phase 4: Citation / Authority Layer Development Build the public evidence layer with clinical references, verified reviews, comparison content, and authoritative citations that AI systems can retrieve and trust for shortlist inclusion.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track Cerebral's recommendation coverage, top-three rate, rank-one rate, and sentiment across all platforms and clusters to measure improvement and identify emerging gaps.

Why This Matters

AI systems are increasingly the first stop for therapy seekers. When a consumer asks for the best online therapy platform or compares pricing between services, the AI returns a synthesized shortlist built from available public sources. Cerebral is present in these responses but is not being selected for shortlists. This gap between visibility and recommendation means the brand is referenced during the research stage but effectively absent at the decision moment.

The commercial implication is direct. Platforms that earn consistent ranked recommendations across multiple buyer stages capture disproportionate value from AI-led discovery. Platforms that are merely present without recommendation credit are visible to AI systems but invisible to the buyer's choice set. Cerebral's next move must be to build the public evidence layer that AI systems trust for shortlist inclusion, not merely accumulate mention presence.

Core Metrics

• Mentions: 145
• Valid recommendations: 50
• Top 3 recommendation count: 20
• Rank 1 recommendation count: 7
• Average recommended rank: 3.7
• Positive mentions: 59
• Neutral mentions: 86
• Negative mentions: 0
• Raw mention presence rate: 11.6%
• Valid recommendation coverage: 4.0%
• Top 3 recommendation rate: 1.6%
• Rank 1 recommendation rate: 0.6%
• Strongest cluster by recommendation behavior: Online Therapy Platform Comparisons (C02)
• Strongest platform by recommendation behavior: Copilot

Sentiment Score

Sentiment Score = (59 positive x 1 + 86 neutral x 0 + 0 negative x -1) / 145 total mentions = 0.41

This score means Cerebral's AI framing is moderately positive but heavily weighted toward neutral references. The 0.41 score is lower than Grow Therapy (0.68) and Brightside Health (0.79), indicating that when Cerebral is mentioned, it is more likely to be a factual reference than a positive endorsement.

Unclassified mention counts are misleading because they treat neutral references and positive recommendations as equal signals. Share of voice is a diagnostic metric, not a business KPI, because a positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention carry fundamentally different commercial weight. Counting all mentions as wins produces bad measurement. Classified sentiment is required before interpreting AI visibility meaningfully.

Sentiment by Platform

Methodology

1. Report orientation: This is a benchmark-based AI Company Market Strategy Report for Cerebral, derived from the LLM Authority Index 2026 AI Market Discovery Index for Online Therapy. It is not a client implementation case study.
2. Reporting window: June 2026, based on a snapshot of AI platform outputs captured during the reporting month.
3. AI platforms tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity.
4. Observation count: 1,252 total observations across all platforms and clusters. Cerebral-specific observations totaled 145.
5. Competitor universe: BetterHelp, Talkspace, Grow Therapy, Brightside Health, Online-Therapy.com, 7 Cups, Amwell, Cerebral, Regain, Calmerry.
6. Public clusters used: Three high-intent clusters were analyzed: Best Online Therapy Platforms (consideration stage), Online Therapy Platform Comparisons (evaluation stage), and Online Therapy Pricing and Cost (decision stage). The full LLM Authority Index report includes 10 clusters.
7. Stage 0 role: The metrics aggregation dataset (stage 0) was the primary source for all quantitative findings in this report.
8. Definition of a mention: A mention means the company appeared in an AI-generated response, regardless of sentiment or rank.
9. Definition of a valid recommendation: A valid recommendation is a positive, shortlist-quality recommendation or ranked recommendation that earns recommendation credit. Visibility is not the same as recommendation credit, and this distinction is central to how the benchmark is interpreted.
10. Limitations: This is a point-in-time benchmark. AI outputs can change with model updates, source changes, and prompt variations. Modeled values are estimates based on commercial intent signals and are not revenue. This report is not a full audit or full market census. Platform weights are applied equally across all tested AI systems. The unique prompt count for the public version of this report is not disclosed in the available dataset.

See How AI Is Recommending Your Brand

The benchmark shows where Cerebral stands across the online therapy category in June 2026. A company-specific analysis would show which prompts Cerebral wins or loses at the individual prompt level, which AI platforms are under-recognizing the brand, which sources are shaping current shortlist decisions, and what changes may improve recommendation-stage visibility. CiteWorks Studio maps exactly where your brand is being recommended, where competitors are being chosen instead, and which layers of the public evidence footprint need to be built or corrected.